Search company, investor...

Predict your next investment

Asset/Investment Management

Broadlawn Capital Management

broadlawncapital.com

Are you a vendor? Get in front of potential partners similar to Broadlawn Capital Management by briefing our analysts.

Submitters are 7x more likely to receive a qualified connection. Learn more.

Investments

About Broadlawn Capital Management

Broadlawn Capital Management is based in Great Neck, New York.

Headquarters Location

40 Cuttermill Road

Great Neck, New York, 11021-3213,

United States

Want to inform investors similar to Broadlawn Capital Management about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Broadlawn Capital Management Investments

1 Investments

Broadlawn Capital Management has made 1 investments. Their latest investment was in Alaunos Therapeutics as part of their PIPE on May 5, 2006.

Broadlawn Capital Management Investments Activity

Date	Round	Company	Amount	New?	Co-Investors	Sources
5/5/2006	PIPE	Alaunos Therapeutics	$37M	Yes	Abu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, FCP OP MEDICAL BioHelth-Trends, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, Knott Partners, LBi International, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management

Date	5/5/2006
Round	PIPE
Company	Alaunos Therapeutics
Amount	$37M
New?	Yes
Co-Investors	Abu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, FCP OP MEDICAL BioHelth-Trends, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, Knott Partners, LBi International, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management
Sources

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

Wells Fargo Success Story

Professional Services

Platform Overview